Full-Time

Director – Investor Relations

Editas Medicine

Editas Medicine

201-500 employees

Clinical stage genome editing for disease treatment

Biotechnology

Senior, Expert

Cambridge, MA, USA

Required Skills
Communications
PowerPoint/Keynote/Slides
Requirements
  • Bachelor's degree required; MBA or related graduate degree preferred
  • Deep understanding of capital markets and financing strategies
  • Investment experience (sellside or buyside) or strategy/management consulting background highly desirable
  • Outstanding presentation and interpersonal skills with the ability to translate complex financial and investment information and to translate complex science into mainstream language and understanding
  • High degree of proficiency in Microsoft Office, including PowerPoint for investor presentations and Excel for financial modeling
  • 10+ years of experience, with at least 3-5 years of investor relations at a life sciences company or in the investment community
  • Well versed in filings and compliance with the SEC
  • A persuasive and energetic communicator who is engaging and effective in oral and written communications
  • An outstanding presence with the ability to gain credibility, rapport, and support with internal and external stakeholders
  • Ability to quickly learn complex and dynamic issues
  • Excellent interpersonal skills - ability to work with executives across diverse functional groups and translate complex concepts into clear, concise, and compelling messages
  • Flexible and adaptable; comfortable with change and ability to adapt to dynamic and evolving priorities and respond to variable timelines with accuracy and urgency
Responsibilities
  • Develop and execute the company's investor relations strategy
  • Maintain comprehensive, current knowledge of Editas' research and development approaches and business strategies to better inform IR strategy
  • Develop and manage relationships and maintain regular communication with investors and analysts, to provide up-to-date information

Company Stage

N/A

Total Funding

$884.6M

Headquarters

Cambridge, Massachusetts

Founded

2013

Growth & Insights
Headcount

6 month growth

11%

1 year growth

19%

2 year growth

11%
INACTIVE